The Nanostructured Lipid Carrier (NLC) that can be inhaled to deliver an anticancer drug directly to the lungs (Image: Oregon State University)
According to American Cancer Society estimates, lung cancer will account for 27 percent of all US cancer deaths in 2013, making it by far the leading cause of cancer death among both men and women. Part of the problem is getting the toxic chemotherapeutic drugs used to treat the cancer into the lungs. A new drug delivery system aims to overcome this problem by allowing the drugs to be inhaled, thereby delivering the drug where it is needed while reducing the harmful effects to other organs.
Other Images from this Gallery